Designating October 13, 2023, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.
By officially designating this day, HR164 aims to enhance public awareness and understanding of metastatic breast cancer, which is crucial for fostering community support and advocacy. This measure encourages educational activities related to the disease, aiming to facilitate discussions around its prevention, treatment, and the experiences of those living with it. Ultimately, the resolution can lead to increased focus on breast cancer resources within state-supported health initiatives.
House Resolution 164 is a legislative measure aimed at designating October 13, 2023, as 'Metastatic Breast Cancer Awareness Day' in Pennsylvania. This initiative is intended to promote awareness regarding metastatic breast cancer, a critical health issue that affects many individuals and families. Through this resolution, the state seeks to highlight the significance of understanding the impact of this disease on patients and to encourage further research and support for those affected by it.
The sentiment surrounding HR164 is largely positive, reflecting a shared community interest in raising awareness about metastatic breast cancer. Many legislators and advocates have expressed support for this resolution as a necessary step towards highlighting a significant health concern and advocating for those impacted. The universal hope is that increased awareness will lead to better health outcomes through enhanced understanding and support for research.
While the bill is primarily non-controversial, the discussions surrounding it may have touched on broader themes related to public health funding and the need for sustained advocacy for patients with metastatic conditions. Nevertheless, no significant points of contention were noted in the voting history, where the bill received overwhelming support with 202 votes in favor and only 1 in opposition. This demonstrates a strong legislative consensus on the importance of recognizing this day.